1. Home
  2. FHI vs ICUI Comparison

FHI vs ICUI Comparison

Compare FHI & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHI
  • ICUI
  • Stock Information
  • Founded
  • FHI 1955
  • ICUI 1984
  • Country
  • FHI United States
  • ICUI United States
  • Employees
  • FHI N/A
  • ICUI N/A
  • Industry
  • FHI Investment Managers
  • ICUI Medical/Dental Instruments
  • Sector
  • FHI Finance
  • ICUI Health Care
  • Exchange
  • FHI Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • FHI 3.1B
  • ICUI 3.5B
  • IPO Year
  • FHI N/A
  • ICUI 1992
  • Fundamental
  • Price
  • FHI $42.67
  • ICUI $142.87
  • Analyst Decision
  • FHI Hold
  • ICUI Buy
  • Analyst Count
  • FHI 6
  • ICUI 5
  • Target Price
  • FHI $42.33
  • ICUI $197.50
  • AVG Volume (30 Days)
  • FHI 850.3K
  • ICUI 269.6K
  • Earning Date
  • FHI 04-24-2025
  • ICUI 05-08-2025
  • Dividend Yield
  • FHI 3.18%
  • ICUI N/A
  • EPS Growth
  • FHI 2.09
  • ICUI N/A
  • EPS
  • FHI 3.58
  • ICUI N/A
  • Revenue
  • FHI $1,659,262,000.00
  • ICUI $2,382,046,000.00
  • Revenue This Year
  • FHI $6.24
  • ICUI $0.84
  • Revenue Next Year
  • FHI $3.75
  • ICUI $2.91
  • P/E Ratio
  • FHI $11.95
  • ICUI N/A
  • Revenue Growth
  • FHI 2.19
  • ICUI 5.44
  • 52 Week Low
  • FHI $31.24
  • ICUI $95.44
  • 52 Week High
  • FHI $43.92
  • ICUI $196.26
  • Technical
  • Relative Strength Index (RSI)
  • FHI 68.52
  • ICUI 54.65
  • Support Level
  • FHI $41.04
  • ICUI $131.73
  • Resistance Level
  • FHI $40.66
  • ICUI $142.00
  • Average True Range (ATR)
  • FHI 1.02
  • ICUI 5.87
  • MACD
  • FHI 0.45
  • ICUI 0.68
  • Stochastic Oscillator
  • FHI 96.45
  • ICUI 89.16

About FHI Federated Hermes Inc.

ederated provides asset management services for institutional and individual investors. The company had $757.6 billion in managed assets at the end of December 2023, composed of equity (10%), multi-asset (less than 1%), fixed-income (13%), alternative (3%), and money market (74%) funds. That said, the firm's cash-management operations are expected to generate around 46% of Federated's revenue this year, compared with 29%, 13%, and 11%, respectively, for the firm's equity, fixed-income, and alternatives/multi-asset operations. From a channel perspective, the company's products are distributed via trust banks, wealth managers and retail broker/dealers (63% of AUM), institutional investors (28%), and international clients (9%).

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: